Hide metadata

dc.date.accessioned2019-11-29T19:24:41Z
dc.date.available2019-11-29T19:24:41Z
dc.date.created2018-12-15T18:14:37Z
dc.date.issued2018
dc.identifier.citationBossard, Cedric Granel, Henri Jallot, Édouard Vial, Christophe Tiainen, Hanna Wittrant, Yohann Lao, Jonathan . Polycaprolactone / bioactive glass hybrid scaffolds for bone regeneration. Biomedical Glasses. 2018, 4, 108-122
dc.identifier.urihttp://hdl.handle.net/10852/71063
dc.description.abstractBioactive glasses (BG) bond to bone and stimulate bone regeneration, but they are brittle. Inorganicorganic hybrids appear as promising bone substitutes since they associate the bone mineral forming ability of BG with the toughness of polymers. Hybrids comprised of polycaprolactone (PCL) and SiO2-CaO BG were produced by sol-gel chemistry and processed into porous scaffolds with controlled pore and interconnection sizes. The obtained scaffolds are highly flexible, meaning that PCL effectively introduces toughness. Apatite formation is observed within 24 hours of immersion in simulated body fluid (SBF) and is not limited to the surface as the entire hybrid progressively changes into bone-like minerals. The degradation rate is suitable for bone regeneration with a 13.2% weight loss after 8 weeks of immersion. Primary osteoblasts cultured in scaffolds demonstrate that the samples are not cytotoxic and provide good cell adhesion. The in vivo study confirms the bioactivity, biocompatibility and suitable degradation rate of the hybrid. A physiological bone made of trabeculae and bone marrow regenerates. The structure and kinetic of bone regeneration was similar to the implanted commercial standard based on bovine bone, demonstrating that this new synthetic PCL-BG hybrid could perform as well as animal-derived bone substitutes.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titlePolycaprolactone / bioactive glass hybrid scaffolds for bone regenerationen_US
dc.typeJournal articleen_US
dc.creator.authorBossard, Cedric
dc.creator.authorGranel, Henri
dc.creator.authorJallot, Édouard
dc.creator.authorVial, Christophe
dc.creator.authorTiainen, Hanna
dc.creator.authorWittrant, Yohann
dc.creator.authorLao, Jonathan
cristin.unitcode185,16,17,62
cristin.unitnameBiomaterialer
cristin.ispublishedtrue
cristin.fulltextoriginal
dc.identifier.cristin1643686
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Biomedical Glasses&rft.volume=4&rft.spage=108&rft.date=2018
dc.identifier.jtitleBiomedical Glasses
dc.identifier.volume4
dc.identifier.startpage108
dc.identifier.endpage122
dc.identifier.doihttps://doi.org/10.1515/bglass-2018-0010
dc.identifier.urnURN:NBN:no-74196
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn2299-3932
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/71063/2/2018_Bossard_Biomedical_Glasses.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International